VANCOUVER, BRITISH COLUMBIA, June 14, 2022. Pascal Biosciences Inc. (“Pascal” or “the Company”) (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF) is announcing a renewed and expanded emphasis on the consulting and contract research component of the business. Pascal has previously had success by…

Read More